The impacts of probiotics in eradication therapy of Helicobacter pylori.

Bai, Xiaofen; Zhu, Minjie; He, Yajun; Wang, Tengyan; Tian, Da; Shu, Jianchang

Bai, Xiaofen; Zhu, Minjie; He, Yajun; Wang, Tengyan; Tian, Da; Shu, Jianchang.

Afiliação

Bai X; Department of Gastroenterology, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, China.
Zhu M; Department of Gastroenterology, Guangzhou Panyu Central Hospital, Guangzhou, China.
He Y; Department of Gastroenterology, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, China.
Wang T; Department of Clinic Laboratory, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, China.
Tian D; Department of Gastroenterology, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, China.
Shu J; Department of Gastroenterology, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, China.

Arch Microbiol ; 204(12): 692, 2022 Nov 07.

Article em En | MEDLINE | ID: mdl-36344628

Assuntos

Microbioma Gastrointestinal; Infecções por Helicobacter; Helicobacter pylori; Probióticos; Humanos; Infecções por Helicobacter/tratamento farmacológico; Probióticos/uso terapêutico; Antibacterianos/efeitos adversos

Palavras-chave

Eradication therapy; Helicobacter pylori; Probiotics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Helicobacter pylori / Infecções por Helicobacter / Probióticos / Microbioma Gastrointestinal Limite: Humans Idioma: En Revista: Arch Microbiol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google